Cancer BiologybioRxiv
Mitochondrial Dysfunction is a Driver for SP-2509 Drug Resistance in Ewing Sarcoma
E. J. P. Tokarsky, J. C. Crow, L. M. Guenther…·E. R. Theisen
The paper identifies mitochondrial dysfunction as a mechanism of resistance to the LSD1 inhibitor SP-2509 in Ewing sarcoma and suggests combining LSD1 inhibitors with mitochondrial-targeting agents.
DOI 10.1158/1541-7786.mcr-22-0027